Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2019 as follows. Summary The Company
Ref U. SET 017/2017 7 August 2017 Subject: Summary of Operating Performance and Financial Status for Quarter 2/2017 To: President The Stock Exchange of Thailand U City Public Company Limited and its
report and consolidated financial statements 2) A summary of the operating results of the listed company and its subsidiaries for the second quarter of the year 2017 (F45-3) Jasmine International Public
of Solvay Biochemicals (Taixing) Limited (“SBT”) amounting to 218 MB. Summary of Performance For Q2 2017, the Company and its subsidiaries recorded net profit of 384 MTHB, increased by 249 MTHB or 5.0
: President of the Stock Exchange of Thailand Enclosures : 1) A copy of financial report and consolidated financial statements 2) A summary of the operating results of the listed company and subsidiaries of the
. * Note Please find further information in the consolidated financial statements. 2 Summary of Performance For Q3 2017, the Company and its subsidiaries recorded net profit of 355 MTHB, increased by 267
: Price depending on the actual negotiated transaction prices between the buyer and seller (Referring to the book value as of December 31, 2016 at Baht 150.89 per share) Summary of financial statements
Lime operating a 7th kiln and adding 15% production capacity, will positively impact revenue in Q1 2018. 3. Financial highlights (based on Thai FRS) Q4 2017 Financial Position Summary as of 31 December
ส่วนที่ 1 สรุปข้อมูลสำคัญของตราสาร (fact sheet) 07 มีนาคม 2565 ส่วนที่ 2 ข้อมูลสรุป (executive summary) 07 มีนาคม 2565 ส่วนที่ 3 ผู้ออกตราสารหนี้ 3.1 วัตถุประสงค์การใช้เงิน 07 มีนาคม 2565